Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 2
1991 5
1992 2
1993 1
1994 5
1995 5
1996 5
1997 4
1998 8
1999 11
2000 7
2001 10
2002 15
2003 6
2004 2
2005 14
2006 10
2007 15
2008 17
2009 15
2010 15
2011 10
2012 11
2013 17
2014 29
2015 17
2016 27
2017 30
2018 33
2019 30
2020 26
2021 30
2022 47
2023 33
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Ketogenic Diet in the Treatment of Neurological Diseases.
Dyńka D, Kowalcze K, Paziewska A. Dyńka D, et al. Nutrients. 2022 Nov 24;14(23):5003. doi: 10.3390/nu14235003. Nutrients. 2022. PMID: 36501033 Free PMC article. Review.
The aim of this paper is a widespread, thorough analysis of the available scientific evidence in respect of the role of the ketogenic diet in the therapy of neurological diseases such as: epilepsy, Alzheimer's disease (AD), Parkinson's disease (PD), mu …
The aim of this paper is a widespread, thorough analysis of the available scientific evidence in respect of the role of the ketogenic diet i …
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A. Petersen RC, et al. Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27. Neurology. 2018. PMID: 29282327 Free PMC article.
RESULTS: MCI prevalence was 6.7% for ages 60-64, 8.4% for 65-69, 10.1% for 70-74, 14.8% for 75-79, and 25.2% for 80-84. Cumulative dementia incidence was 14.9% in individuals with MCI older than age 65 years followed for 2 years. ...
RESULTS: MCI prevalence was 6.7% for ages 60-64, 8.4% for 65-69, 10.1% for 70-74, 14.8% for 75-79, and 25.2% for 80-84. Cumulative de …
Medical Care of Adults With Down Syndrome: A Clinical Guideline.
Tsou AY, Bulova P, Capone G, Chicoine B, Gelaro B, Harville TO, Martin BA, McGuire DE, McKelvey KD, Peterson M, Tyler C, Wells M, Whitten MS; Global Down Syndrome Foundation Medical Care Guidelines for Adults with Down Syndrome Workgroup. Tsou AY, et al. JAMA. 2020 Oct 20;324(15):1543-1556. doi: 10.1001/jama.2020.17024. JAMA. 2020. PMID: 33079159 Review.
EVIDENCE REVIEW: The Global Down Syndrome Foundation Medical Care Guidelines for Adults with Down Syndrome Workgroup (n = 13) developed 10 Population/Intervention/ Comparison/Outcome (PICO) questions for adults with Down syndrome addressing multiple clinical areas includin …
EVIDENCE REVIEW: The Global Down Syndrome Foundation Medical Care Guidelines for Adults with Down Syndrome Workgroup (n = 13) develop …
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.
Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Norton S, et al. Lancet Neurol. 2014 Aug;13(8):788-94. doi: 10.1016/S1474-4422(14)70136-X. Lancet Neurol. 2014. PMID: 25030513 Free article.
BACKGROUND: Recent estimates suggesting that over half of Alzheimer's disease burden worldwide might be attributed to potentially modifiable risk factors do not take into account risk-factor non-independence. ...METHODS: Using relative risks from existing meta-analy …
BACKGROUND: Recent estimates suggesting that over half of Alzheimer's disease burden worldwide might be attributed to potentia …
The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.
Varesi A, Pierella E, Romeo M, Piccini GB, Alfano C, Bjørklund G, Oppong A, Ricevuti G, Esposito C, Chirumbolo S, Pascale A. Varesi A, et al. Nutrients. 2022 Feb 5;14(3):668. doi: 10.3390/nu14030668. Nutrients. 2022. PMID: 35277027 Free PMC article. Review.
More recently, gut microbiome alterations have been linked to neurodegeneration through the increasingly defined gut microbiota brain axis, opening the possibility for new microbiota-based therapeutic options. Although several studies have been conducted to unravel the pos …
More recently, gut microbiome alterations have been linked to neurodegeneration through the increasingly defined gut microbiota brain axis, …
Copenhagen Consensus statement 2019: physical activity and ageing.
Bangsbo J, Blackwell J, Boraxbekk CJ, Caserotti P, Dela F, Evans AB, Jespersen AP, Gliemann L, Kramer AF, Lundbye-Jensen J, Mortensen EL, Lassen AJ, Gow AJ, Harridge SDR, Hellsten Y, Kjaer M, Kujala UM, Rhodes RE, Pike ECJ, Skinner T, Skovgaard T, Troelsen J, Tulle E, Tully MA, van Uffelen JGZ, Viña J. Bangsbo J, et al. Br J Sports Med. 2019 Jul;53(14):856-858. doi: 10.1136/bjsports-2018-100451. Epub 2019 Feb 21. Br J Sports Med. 2019. PMID: 30792257 Free PMC article.
Nevertheless, we also considered research with frail older adults and those with age-associated neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, and in a few cases molecular and cellular outcome measures from animal studies. ...
Nevertheless, we also considered research with frail older adults and those with age-associated neurodegenerative diseases, such as Alzhe …
Cannabinoids for the treatment of dementia.
Bosnjak Kuharic D, Markovic D, Brkovic T, Jeric Kegalj M, Rubic Z, Vuica Vukasovic A, Jeroncic A, Puljak L. Bosnjak Kuharic D, et al. Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2. Cochrane Database Syst Rev. 2021. PMID: 34532852 Free PMC article. Review.
MAIN RESULTS: We included four studies (126 participants) in this review. Most participants had Alzheimer's disease; a few had vascular dementia or mixed dementia. ...Three trials had a cross-over design. Interventions were applied over 3 to 14 weeks; one stu …
MAIN RESULTS: We included four studies (126 participants) in this review. Most participants had Alzheimer's disease; a few had …
Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
Cai T, Abel L, Langford O, Monaghan G, Aronson JK, Stevens RJ, Lay-Flurrie S, Koshiaris C, McManus RJ, Hobbs FDR, Sheppard JP. Cai T, et al. BMJ. 2021 Jul 14;374:n1537. doi: 10.1136/bmj.n1537. BMJ. 2021. PMID: 34261627 Free PMC article.
OBJECTIVE: To assess the associations between statins and adverse events in primary prevention of cardiovascular disease and to examine how the associations vary by type and dosage of statins. ...Statins were associated with an increased risk of self-reported muscle sympto …
OBJECTIVE: To assess the associations between statins and adverse events in primary prevention of cardiovascular disease and to exami …
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. Farrer LA, et al. JAMA. 1997 Oct 22-29;278(16):1349-56. JAMA. 1997. PMID: 9343467
OBJECTIVE: To examine more closely the association between apolipoprotein E (APOE) genotype and Alzheimer disease (AD) by age and sex in populations of various ethnic and racial denominations. DATA SOURCES: Forty research teams contributed data on APOE genotype, sex …
OBJECTIVE: To examine more closely the association between apolipoprotein E (APOE) genotype and Alzheimer disease (AD) by age …
Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.
Veitch DP, Weiner MW, Aisen PS, Beckett LA, DeCarli C, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative. Veitch DP, et al. Alzheimers Dement. 2022 Apr;18(4):824-857. doi: 10.1002/alz.12422. Epub 2021 Sep 28. Alzheimers Dement. 2022. PMID: 34581485 Free PMC article. Review.
METHODS: We identified 1442 publications using ADNI data by conventional search methods and selected impactful studies for inclusion. RESULTS: Disease progression studies supported pivotal roles for regional amyloid beta (Abeta) and tau deposition, and identified underlyin …
METHODS: We identified 1442 publications using ADNI data by conventional search methods and selected impactful studies for inclusion. RESULT …
489 results